Allspring Global Investments Holdings, LLC Athenex, Inc. Transaction History

Allspring Global Investments Holdings, LLC

$62.1 Billion
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 25, 2022	SELL	$0.41 - $0.91 $6,686 - $14,841	-16,309 Closed	0 $0
Q1 2022 May 02, 2022	BUY	$0.79 - $1.59 $9,887 - $19,900	12,516 Added 329.98%	16,309 $13,000
Q4 2021 Jan 28, 2022	BUY	$1.36 - $2.94 $5,158 - $11,151	3,793 New	3,793 $5,000

Others Institutions Holding ATNX

# of Institutions

Shares Held

1.46M

Call Options Held

Put Options Held

Empery Asset Management, LP New York, NY

1.45M
Shares

$14,521
2.33% of portfolio
Eaton Vance Management Boston, MA

12K
Shares

$120
0.0% of portfolio
Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

View Full List

About Athenex, Inc.

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

More about ATNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Account